Company Quick10K Filing
Pivot Pharmaceuticals
20-F 2020-01-31 Filed 2020-06-01
10-Q 2019-04-30 Filed 2019-06-17
10-K 2019-01-31 Filed 2019-05-03
10-Q 2018-10-31 Filed 2018-12-18
10-Q 2018-07-31 Filed 2018-09-14
10-Q 2018-04-30 Filed 2018-06-19
10-K 2018-01-31 Filed 2018-05-01
10-Q 2017-10-31 Filed 2017-12-15
10-Q 2017-07-31 Filed 2017-09-15
10-Q 2017-04-30 Filed 2017-06-13
10-K 2017-01-31 Filed 2017-04-28
10-Q 2016-10-31 Filed 2016-12-12
10-Q 2016-07-31 Filed 2016-09-12
10-Q 2016-04-30 Filed 2016-06-14
10-K 2016-01-31 Filed 2016-04-29
10-Q 2015-10-31 Filed 2015-12-15
10-Q 2015-07-31 Filed 2015-09-10
10-Q 2015-01-31 Filed 2015-06-17
10-K 2015-01-31 Filed 2015-05-15
10-Q 2014-10-31 Filed 2014-12-15
10-Q 2014-07-31 Filed 2014-09-15
10-Q 2014-04-30 Filed 2014-06-16
10-K 2014-01-31 Filed 2014-05-16
10-Q 2013-10-31 Filed 2013-12-16
10-Q 2013-07-31 Filed 2013-09-16
10-Q 2013-04-30 Filed 2013-06-19
10-K 2013-01-31 Filed 2013-05-16
10-Q 2012-10-31 Filed 2012-12-14
10-Q 2012-07-31 Filed 2012-09-14
10-Q 2012-04-30 Filed 2012-06-14
10-K 2012-01-31 Filed 2012-05-14
10-Q 2011-10-31 Filed 2011-12-15
10-Q 2011-07-31 Filed 2011-09-14
10-Q 2011-04-30 Filed 2011-06-14
10-K 2011-01-31 Filed 2011-05-11
10-Q 2010-10-31 Filed 2010-12-15
10-Q 2010-07-31 Filed 2010-09-14
10-Q 2010-04-30 Filed 2010-06-21
10-K 2010-01-31 Filed 2010-05-28
8-K 2019-05-21
8-K 2019-01-29
8-K 2018-12-19
8-K 2018-11-06
8-K 2018-09-18
8-K 2018-03-12

Pivot Pharmaceuticals Financials

PVOTF Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Yinfu Gold (ELRE) 29,852 -141.2 -4,499% 5 1,503 0 0 -211 -211 29,852
Stellar Acquisition III (STLR) 29,826 -36.9 -4% 19,551 2,728 0 0 -808 -808 29,807
BioCardia (BCDA) 29,690 35% -1.9 -105% 10,681 5,487 496 175 -11,207 -11,017 20,780
IMAC Holdings (IMAC) 29,575 0% -8.6 -24% 21,017 13,255 10,882 0 -5,049 -3,754 32,402
Envision Solar (EVSI) 29,558 8% -13.5 -28% 9,021 1,982 4,616 349 -2,544 -1,802 24,266
MobileSmith (MOST) 29,402 63% -16.5 -445% 1,788 50,989 2,180 1,371 -7,954 -4,314 71,177
Butler National (BUKS) 29,341 0% 1.2 7% 95,267 56,460 66,462 0 6,448 12,592 15,293
SMG Industries (SMGI) 29,047 19% -24.0 -31% 7,464 6,968 4,911 912 -2,297 -1,314 31,523
Greenway Technologies (UMED) 28,886 -7.1 -2,498% 165 6,716 0 0 -4,130 -4,130 29,391
JetPay (JTPY) 28,637 41% 6.8 -1% 171,416 107,921 66,457 26,994 -1,047 4,875 33,287
Zivo Bioscience (ZIVO) 28,620 -3.9 -10,555% 70 10,973 0 0 -7,378 -7,378 28,605
Pivot Pharmaceuticals (PVOTF) 28,605 -4.6 -70% 9,549 6,181 0 0 -6,666 -6,195 28,560
Jones Soda (JSDA) 28,533 21% -10.6 -24% 11,202 3,488 11,685 2,432 -2,670 -2,025 21,562
General Cannabis (CANN) 28,438 73% -3.3 -210% 4,611 5,703 4,225 3,065 -9,663 -9,239 30,057
Investview (INVU) 28,403 95% -3.1 -74% 12,478 16,067 22,487 21,461 -9,179 -8,893 27,145
Cannabics Pharmaceuticals (CNBX) 27,044 31% 14.8 9% 19,772 454 11 3 1,794 1,794 26,551
United Cannabis (CNAB) 28,154 4% -1.6 -193% 9,051 14,945 13,098 487 -17,423 -16,727 27,588
Q Biomed (QBIO) 27,006 -4.5 -1,090% 682 5,043 0 0 -7,437 -6,777 30,497
Advanzeon (CHCR) 27,618 70% -14.6 -100% 2,742 30,704 301 210 -2,746 -2,746 40,162
Jerrick Media Holdings (JMDA) 27,492 100% -5.4 -192% 2,815 8,728 133 133 -5,404 -5,075 27,325

Balance Sheet ($'000)2011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-01-312015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-30
Cash62321015181051134270188722932071124710250651,5114744077545
Accounts Receivable0118
Inventory7
PP&E2221111111110000000066650
Assets777762171477128235272208106551822913366365353848,8147,5877,0808,5969,549
Accounts Payable
Long-Term Debt
Liabilities3964375596206816667017357585736157797195921444355647221,3901,6071,7991,3213524294,2214,2873,6515,0866,181
Stockholders' Equity-388-430-553-613-675-646-694-770-748-771-69-6018064-329-509-704-1,162-1,474-1,733-1,284183-454,5933,3013,4293,5103,369
Income Statement ($'000)2011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-01-312015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-30
Revenue00000000000000000000000
Cost of Revenue
Gross Profit
R&D1000000000085876559
SG&A132-1952754312553141434241292215796271552537650165756428432507
Tax000000000000000000000000
Net Income130-960594-123-61-69-49-37-602-5591-36-168-889-1,458-2,937-10-4,196-3,332-1,179-955-812-320-6531-327-1,624-1,414-3,378-1,874
Cash Flow ($'000)2011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-01-312015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-30
Cash Operating-3-29-2-1-1-0-20-6-1-15-11-45-16-25-82-41-79-35-162-101-68-61-71-196-1,872-983-706-568
Cash Investing000000000-3330-3270
Cash Financing030000150103045492610-700333650322307283,670-85998526